American Well Corp's (NYSE:AMWL) Chief Accounting Officer, Paul Francis McNeice, has sold shares of the company's stock, according to a recent SEC filing. The transaction was executed on September 3, 2024, with McNeice disposing of 165 shares at a price of $7.8719 per share. The total value of the shares sold amounted to approximately $1,298.
This sale was conducted to cover the tax liability associated with the vesting and settlement of restricted stock units. The filing noted that the shares were sold through an automatic "sell to cover" transaction, indicating that this was not a discretionary trade by McNeice. Following this transaction, McNeice's ownership in the company stands at 9,507 shares of Class A Common Stock.
Investors often watch insider transactions as they provide insights into how executives view the company's stock value and potential future performance. However, in this case, the transaction appears to be solely for the purpose of meeting tax obligations rather than reflecting a change in the executive's view of the company's financial prospects.
American Well Corp, based in Boston, Massachusetts, operates in the business services sector, providing telehealth solutions that connect patients with healthcare providers remotely.
For those tracking insider transactions, this recent filing offers a glimpse into the financial decisions made by American Well Corp's executives, particularly in relation to their compensation and tax planning strategies.
In other recent news, American Well Corp reported a second-quarter 2024 revenue of $63 million, surpassing consensus estimates, and an adjusted EBITDA loss of $35 million, which was less than the projected $40 million loss. The company confirmed its revenue outlook for 2024 and improved its adjusted EBITDA forecast by $10 million, attributing this to effective cost management strategies. Following these results, TD Cowen increased the price target for the company to $12.00, up from the previous $2.00, while maintaining a Hold rating on the stock.
American Well also announced an amendment to the employment agreement with Kathy Weiler, the Chief Commercial & Growth Officer. The amendment includes benefits for Weiler if she leaves her position without a "Good Reason" after June 1, 2025, such as accrued compensation, a pro rata bonus for the year of termination, a year's base salary paid over 12 months, and immediate vesting of certain unvested equity awards.
Other recent developments include the company receiving positive initial feedback from the Defense Health Agency (DHA) and successful deployment of its services. Furthermore, American Well has announced a series of expansions and renewals, indicating customer satisfaction with its Converge platform. Lastly, leadership changes have taken place with Co-founder Roy Schoenberg transitioning to Executive Vice Chairman of the company's Board of Directors, and Ido Schoenberg assuming the role of sole Chief Executive Officer.
InvestingPro Insights
As American Well Corp (NYSE:AMWL) navigates the competitive telehealth market, recent insider transactions and market performance provide a broader context for investors. According to InvestingPro data, AMWL has a market capitalization of approximately $119.93 million, which reflects the size and scale of the company within the industry. The company's price-to-book ratio for the last twelve months as of Q2 2024 stands at a modest 0.33, suggesting that the stock may be undervalued relative to the company's asset base.
Despite the insider selling for tax liability purposes, it's important for investors to consider the company's financial health and market performance. An InvestingPro Tip highlights that AMWL is quickly burning through cash. This, coupled with the fact that analysts do not anticipate the company to be profitable this year, could be a concern for potential investors. On a more positive note, another InvestingPro Tip points out that AMWL holds more cash than debt on its balance sheet, which is a strong indicator of financial stability in the short term.
Investors should also be aware of the stock's recent trajectory. AMWL's stock has fared poorly over the last month, with an 18.51% decline, and has taken a significant hit over the last six months, plummeting by 62.18%. These metrics may influence investor sentiment and decision-making, especially when considering the company's long-term growth potential and the broader trends in the telehealth industry.
For those interested in a deeper dive into American Well Corp's financials and market performance, InvestingPro offers additional tips and real-time metrics. There are currently 10 more InvestingPro Tips available, which can provide investors with a more comprehensive understanding of the company's prospects and challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.